The neurological effects of tunicamycin may reduce its potential as an anticancer agent.
D000818:Animals; D000970:Antineoplastic Agents; D006017:Glycolipids / Q000633:toxicity; D009422:Nervous System Diseases / Q000139:chemically induced*; D051381:Rats; D012756:Sheep; D014415:Tunicamycin / Q000633:toxicity*
D000970:Antineoplastic Agents; D006017:Glycolipids; C034696:corynetoxins; D014415:Tunicamycin